BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20471472)

  • 1. Molecular basis of lysophosphatidic acid-induced NF-κB activation.
    Sun W; Yang J
    Cell Signal; 2010 Dec; 22(12):1799-803. PubMed ID: 20471472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation.
    Sun J; Lin X
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17085-90. PubMed ID: 18952848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LUBAC participates in lysophosphatidic acid-induced NF-κB activation.
    Douanne T; Chapelier S; Rottapel R; Gavard J; Bidère N
    Cell Immunol; 2020 Jul; 353():104133. PubMed ID: 32450431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.
    Klemm S; Zimmermann S; Peschel C; Mak TW; Ruland J
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):134-8. PubMed ID: 17095601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEKK3 is required for lysophosphatidic acid-induced NF-kappaB activation.
    Sun W; Li H; Yu Y; Fan Y; Grabiner BC; Mao R; Ge N; Zhang H; Fu S; Lin X; Yang J
    Cell Signal; 2009 Oct; 21(10):1488-94. PubMed ID: 19465115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
    Wegener E; Krappmann D
    Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
    Grabiner BC; Blonska M; Lin PC; You Y; Wang D; Sun J; Darnay BG; Dong C; Lin X
    Genes Dev; 2007 Apr; 21(8):984-96. PubMed ID: 17438001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
    Mahanivong C; Chen HM; Yee SW; Pan ZK; Dong Z; Huang S
    Oncogene; 2008 Feb; 27(9):1273-80. PubMed ID: 17724468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseases.
    Sun J
    World J Biol Chem; 2010 Dec; 1(12):353-61. PubMed ID: 21537470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl10 plays a critical role in NF-kappaB activation induced by G protein-coupled receptors.
    Wang D; You Y; Lin PC; Xue L; Morris SW; Zeng H; Wen R; Lin X
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):145-50. PubMed ID: 17179215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
    Zhang S; Lin X
    Front Immunol; 2019; 10():176. PubMed ID: 30814996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARMA3 Is a Critical Mediator of G Protein-Coupled Receptor and Receptor Tyrosine Kinase-Driven Solid Tumor Pathogenesis.
    McAuley JR; Freeman TJ; Ekambaram P; Lucas PC; McAllister-Lucas LM
    Front Immunol; 2018; 9():1887. PubMed ID: 30158935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.
    Sun L; Deng L; Ea CK; Xia ZP; Chen ZJ
    Mol Cell; 2004 May; 14(3):289-301. PubMed ID: 15125833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells.
    Medoff BD; Landry AL; Wittbold KA; Sandall BP; Derby MC; Cao Z; Adams JC; Xavier RJ
    Am J Respir Cell Mol Biol; 2009 Mar; 40(3):286-94. PubMed ID: 18757306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Thr-516 and Ser-520 in the kinase activation loop of MEKK3 is required for lysophosphatidic acid-mediated optimal IkappaB kinase beta (IKKbeta)/nuclear factor-kappaB (NF-kappaB) activation.
    Sun W; Ge N; Yu Y; Burlingame S; Li X; Zhang M; Ye S; Fu S; Yang J
    J Biol Chem; 2010 Mar; 285(11):7911-8. PubMed ID: 20068038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.
    McAllister-Lucas LM; Ruland J; Siu K; Jin X; Gu S; Kim DS; Kuffa P; Kohrt D; Mak TW; Nuñez G; Lucas PC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):139-44. PubMed ID: 17101977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.
    Dong W; Liu Y; Peng J; Chen L; Zou T; Xiao H; Liu Z; Li W; Bu Y; Qi Y
    J Biol Chem; 2006 Sep; 281(36):26029-40. PubMed ID: 16831874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphatase 2A acts as a mitogen-activated protein kinase kinase kinase 3 (MEKK3) phosphatase to inhibit lysophosphatidic acid-induced IkappaB kinase beta/nuclear factor-kappaB activation.
    Sun W; Wang H; Zhao X; Yu Y; Fan Y; Wang H; Wang X; Lu X; Zhang G; Fu S; Yang J
    J Biol Chem; 2010 Jul; 285(28):21341-8. PubMed ID: 20448038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid activates NF-kappaB in fibroblasts. A requirement for multiple inputs.
    Shahrestanifar M; Fan X; Manning DR
    J Biol Chem; 1999 Feb; 274(6):3828-33. PubMed ID: 9920937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
    Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
    J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.